Christopher Abraham
Overview
Explore the profile of Christopher Abraham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dover L, Abraham C, Kole A, Weiner A
Pract Radiat Oncol
. 2024 Nov;
PMID: 39515465
Low-dose chest computed tomography imaging for lung cancer screening is revealing increasing numbers of radiographic early-stage lung cancers. This topic discussion describes when a clinical scenario merits radiation therapy without...
2.
Huang J, Campian J, DeWees T, Skrott Z, Mistrik M, Johanns T, et al.
Int J Radiat Oncol Biol Phys
. 2024 May;
120(3):738-749.
PMID: 38768767
Purpose: This phase 1/2 study aimed to evaluate the safety and preliminary efficacy of combining disulfiram and copper (DSF/Cu) with radiation therapy (RT) and temozolomide (TMZ) in patients with newly...
3.
Kape C, Hamelin N, Abraham C
J Gambl Stud
. 2023 Oct;
40(2):937-955.
PMID: 37884853
The focus of this research is to understand the sports gambling intentions of Gen Z (those born between 1997 and 2012) that can potentially lead to problematic gambling behavior. Rooted...
4.
Ghosh S, Johanns T, Chheda M, Liu E, Butt O, Abraham C, et al.
Neurooncol Adv
. 2023 Aug;
5(1):vdad088.
PMID: 37554225
Background: Myeloid-derived suppressor cells (MDSCs) are critical regulators of immunosuppression and radioresistance in glioblastoma (GBM). The primary objective of this pilot phase Ib study was to validate the on-target effect...
5.
Liu H, Clark R, Magliari A, Foster R, Reynoso F, Schmidt M, et al.
Med Dosim
. 2022 May;
47(3):258-263.
PMID: 35513996
Whole-brain radiotherapy has been the standard palliative treatment for patients with brain metastases due to its effectiveness, availability, and ease of administration. Recent clinical trials have shown that limiting radiation...
6.
Hassanzadeh C, Rudra S, Ma S, Brenneman R, Huang Y, Henke L, et al.
Radiother Oncol
. 2021 Feb;
158:237-243.
PMID: 33587967
Background And Purpose: Consensus for defining gross tumor volume (GTV) and clinical target volume (CTV) for limited-field radiation therapy (LFRT) of GBM are not well established. We leveraged a department...
7.
Andruska N, Kennedy W, Bonestroo L, Anderson R, Huang Y, Robinson C, et al.
Radiother Oncol
. 2020 Dec;
156:181-187.
PMID: 33310010
Background: To identify factors predictive of developing symptomatic radiation necrosis (sRN) among patients with either intact or resected brain metastases undergoing five-fraction stereotactic radiosurgery (5fSRS). Methods: Multi-institutional retrospective review of...
8.
Huang J, Milchenko M, Rao Y, LaMontagne P, Abraham C, Robinson C, et al.
PLoS One
. 2020 Nov;
15(11):e0241835.
PMID: 33141861
Background: To explore if early perfusion-weighted magnetic resonance imaging (PWI) may be a promising imaging biomarker to predict local recurrence (LR) of brain metastases after stereotactic radiosurgery (SRS). Methods: This...
9.
Hassanzadeh C, Roach M, Rich K, Karraker P, Robinson C, Michalski J, et al.
Pract Radiat Oncol
. 2020 Feb;
10(4):e250-e254.
PMID: 32004704
Purpose: The medical necessity of stereotactic radiosurgery (SRS) is nonuniform across insurance policies. The American Society for Radiation Oncology (ASTRO) created a model policy based on the consensus of the...
10.
Hagan M, Kapoor R, Michalski J, Sandler H, Movsas B, Chetty I, et al.
Int J Radiat Oncol Biol Phys
. 2020 Jan;
106(3):639-647.
PMID: 31983560
Purpose: We sought to develop a quality surveillance program for approximately 15,000 US veterans treated at the 40 radiation oncology facilities at the Veterans Affairs (VA) hospitals each year. Methods...